S66F (p.Ser66Phe) variant of SLC2A1 (P11166)

S66F (p.Ser66Phe) in SLC2A1 (P11166) is a missense change. Clinical records from EBI and UniProt describe it as pathogenic in the context of in GLUT1DS1. The available variant effect predictions contribute to a CATVariant prioritization score of 0.82 / 1. The record also includes published literature and structural context.

S66F (p.Ser66Phe) variant details